A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Mirae Asset Nifty 500 Healthcare ETF
1 Year Absolute Returns
-
NAV (₹) on 31 Mar 2026
17.87
1 Day NAV Change
0.00%
Risk Level
Very High Risk
Rating
-
Mirae Asset Nifty 500 Healthcare ETF is a Equity mutual fund categorized under ETF, offered by Mirae Asset Global Investments (India) Pvt. Ltd.. Launched on 27 Jan 2026, investors can start with a ... Read more
NAV History
Fund Details
Min. SIP Amount
N/A
Inception Date
27 Jan 2026
Min. Lumpsum Amount
₹ 5,000
Fund Age
0 Yrs
AUM
₹ 7.29 Cr.
Benchmark
Nifty500 Healthcare Total Return
Expense Ratio
0.11%
Scheme Type
Open Ended
Exit Load
Nil%
Asset Allocation
AUM
₹ 7.29 Cr
Equity
99.87%
Money Market & Cash
0.07%
Other Assets & Liabilities
0.06%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 74.28% |
| Hospitals & Medical Services | 24.76% |
| Services - Others | 0.43% |
| Medical Equipment & Accessories | 0.40% |
| Treps/Reverse Repo | 0.07% |
| Net Receivables/(Payables) | 0.06% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.02% | ₹ 0.73 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.80% | ₹ 0.50 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 6.78% | ₹ 0.49 | Hospitals & Medical Services |
| Apollo Hospitals Enterprise Ltd. | 6.72% | ₹ 0.49 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Ltd. | 6.54% | ₹ 0.48 | Pharmaceuticals |
| Cipla Ltd. | 6.33% | ₹ 0.46 | Pharmaceuticals |
| Lupin Ltd. | 4.66% | ₹ 0.34 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 4.10% | ₹ 0.30 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 3.78% | ₹ 0.28 | Pharmaceuticals |
| Laurus Labs Ltd. | 3.49% | ₹ 0.25 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 2.85% | ₹ 0.21 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 2.75% | ₹ 0.20 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.69% | ₹ 0.20 | Pharmaceuticals |
| Biocon Ltd. | 2.32% | ₹ 0.17 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.12% | ₹ 0.15 | Pharmaceuticals |
| Zydus Lifesciences Ltd. | 1.93% | ₹ 0.14 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 1.77% | ₹ 0.13 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 1.54% | ₹ 0.11 | Hospitals & Medical Services |
| JB Chemicals & Pharmaceuticals Ltd. | 1.40% | ₹ 0.10 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 1.27% | ₹ 0.09 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 1.21% | ₹ 0.09 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 1.14% | ₹ 0.08 | Pharmaceuticals |
| Abbott India Ltd. | 1.13% | ₹ 0.08 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 1.05% | ₹ 0.08 | Pharmaceuticals |
| Narayana Hrudayalaya Ltd. | 1.04% | ₹ 0.08 | Hospitals & Medical Services |
| Wockhardt Ltd. | 0.94% | ₹ 0.07 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 0.92% | ₹ 0.07 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 0.90% | ₹ 0.07 | Hospitals & Medical Services |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.89% | ₹ 0.06 | Pharmaceuticals |
| Piramal Pharma Ltd. | 0.81% | ₹ 0.06 | Pharmaceuticals |
| Global Health Ltd. | 0.80% | ₹ 0.06 | Hospitals & Medical Services |
| Natco Pharma Ltd. | 0.74% | ₹ 0.05 | Pharmaceuticals |
| Granules India Ltd. | 0.70% | ₹ 0.05 | Pharmaceuticals |
| Syngene International Ltd. | 0.67% | ₹ 0.05 | Pharmaceuticals |
| Pfizer Ltd. | 0.64% | ₹ 0.05 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 0.62% | ₹ 0.05 | Pharmaceuticals |
| Eris Lifesciences Ltd. | 0.61% | ₹ 0.04 | Pharmaceuticals |
| Jubilant Pharmova Ltd. | 0.58% | ₹ 0.04 | Pharmaceuticals |
| Rainbow Children's Medicare Ltd. | 0.50% | ₹ 0.04 | Hospitals & Medical Services |
| AstraZeneca Pharma India Ltd. | 0.45% | ₹ 0.03 | Pharmaceuticals |
| Indegene Ltd. | 0.43% | ₹ 0.03 | Services - Others |
| Cohance Lifesciences Ltd. | 0.42% | ₹ 0.03 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 0.41% | ₹ 0.03 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Ltd. | 0.41% | ₹ 0.03 | Hospitals & Medical Services |
| Polymedicure Ltd. | 0.40% | ₹ 0.03 | Medical Equipment & Accessories |
| Emcure Pharmaceuticals Ltd. | 0.36% | ₹ 0.03 | Pharmaceuticals |
| Concord Biotech Ltd. | 0.34% | ₹ 0.02 | Pharmaceuticals |
| Alembic Pharmaceuticals Ltd. | 0.33% | ₹ 0.02 | Pharmaceuticals |
| Dr. Agarwals Health Care Ltd. | 0.29% | ₹ 0.02 | Hospitals & Medical Services |
| Caplin Point Laboratories Ltd. | 0.28% | ₹ 0.02 | Pharmaceuticals |
| TREPS | 0.07% | ₹ 0.01 | Others |
| Net Receivables / (Payables) | 0.06% | ₹ 0 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | - | - | - | - |
| Category returns | -7.52% | 0.67% | 4.57% | 20.69% |
Fund Objective
The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty 500 Healthcare Total Return Index, subject to tracking error. ... Read more
AMC Details
Name
Mirae Asset Global Investments (India) Pvt. Ltd.
Date of Incorporation
30 Nov 2007
CEO
Mr. Swarup Anand Mohanty
CIO
Mr. Neelesh Surana, Mr. Mahendra Kumar Jajoo
Type
Foreign
Address
Unit 606, 6th Floor, Windsor,
Off CST Road,
Kalina,
Santacruz (E), Mumbai, Maharashtra, India - 400098
Website
http://www.miraeassetmf.co.in
Email
Top Funds from Others - Index Funds/ETFs
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ICICI Prudential Nifty 50 ETF
ETF
Regular
|
₹251.37 | -4.01% | 33.08% | 60.83% | ₹37,939 | 0.02% |
Very High
|
|
Aditya Birla Sun Life Nifty 50 ETF
ETF
Regular
|
₹26 | -3.99% | 33.05% | 60.82% | ₹3,264 | 0.04% |
Very High
|
|
Nippon India ETF Nifty 50 BeES
ETF
Regular
|
₹252.66 | -4.02% | 33.02% | 60.74% | ₹57,633 | 0.05% |
Very High
|
|
UTI Nifty 50 ETF
ETF
Regular
|
₹245.89 | -4.01% | 33.01% | 60.68% | ₹69,058 | 0.05% |
Very High
|
|
Axis NIFTY 50 ETF
ETF
Regular
|
₹245.51 | -4.04% | 33.00% | 60.66% | ₹1,236 | 0.04% |
Very High
|
|
Motilal Oswal Nifty M50 ETF
ETF
Regular
|
₹232.23 | -4.02% | 32.99% | 60.58% | ₹56 | 0.05% |
Very High
|
|
Mirae Asset Nifty 50 ETF
ETF
Regular
|
₹241.25 | -4.03% | 32.97% | 60.63% | ₹4,766 | 0.04% |
Very High
|
|
HDFC Nifty 50 ETF
ETF
Regular
|
₹249.95 | -4.03% | 32.97% | 60.63% | ₹5,202 | 0.05% |
Very High
|
|
SBI Nifty 50 ETF
ETF
Regular
|
₹238.79 | -4.03% | 32.96% | 60.59% | ₹2,13,394 | 0.04% |
Very High
|
|
DSP Nifty 50 ETF
ETF
Regular
|
₹233.66 | -4.03% | 32.96% | 0.00% | ₹215 | 0.07% |
Very High
|
Top Funds from Mirae Asset Global Investments (India) Pvt. Ltd.
FAQs
What is the current NAV of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The current Net Asset Value (NAV) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹17.87 as of 31 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The Assets Under Management (AUM) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹7.29 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
Mirae Asset Nifty 500 Healthcare ETF Regular Growth has delivered returns of 0.00% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
Mirae Asset Nifty 500 Healthcare ETF Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The minimum lumpsum investment required for Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹5,000. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
SEBI: ಹೂಡಿಕೆದಾರರ ಸುರಕ್ಷತೆಗೆ ಸೆಬಿ ಹೊಸ ಲಾಕ್ ಸೌಲಭ್ಯ…ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹಿಂಪಡೆಯುವಿಕೆ ತಡೆಯಿರಿ! -
Mutual Fund: 10000 ಮಾಸಿಕ SIP 32 ಲಕ್ಷಕ್ಕೆ ಬೆಳವಣಿಗೆ...1, 3, 5, 10 ವರ್ಷದ ಲಾಭ ಮತ್ತು ಹೂಡಿಕೆ ಕಾರ್ಯವಿಧಾನ! -
Mutual Funds: ನಿವೃತ್ತಿ ಜೀವನದಲ್ಲಿ ಸ್ಥಿರ ಆದಾಯ ಬೇಕಾ? ಈ 4 ರೀತಿಯ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ಗಳು ನಿಮಗೆ ಬೆಸ್ಟ್ ಆಯ್ಕೆ! -
Mutual Funds: ಕೆವೈಸಿ ಇಲ್ಲದೆಯೂ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ಗಳಲ್ಲಿ ಹೂಡಿಕೆ ಮಾಡಬಹುದಾ? ಇಲ್ಲಿದೆ ರಹಸ್ಯ -
Investment Plan: ಎಫ್ಡಿ vs ಮ್ಯೂಚುವಲ್ ಫಂಡ್ vs ಚಿನ್ನ; ಹೂಡಿಕೆಗೆ ಯಾವುದು ಬೆಸ್ಟ್? -
SIP Investment Plan: ತಿಂಗಳಿಗೆ 2026 ರೂ. ಉಳಿಸಿದ್ರೆ ಸಾಕು, ಲಕ್ಷಗಟ್ಟಲೆ ಗಳಿಸಬಹುದು! ಈ ಸೂತ್ರವೊಂದು ಗೊತ್ತಿದ್ರೆ ಸಾಕು -
SIP: ಎಸ್ಐಪಿಯಲ್ಲಿ ಹೂಡಿಕೆ ಮಾಡುವವರು ತಿಳಿಯಲೇಬೇಕಾದ ವಿಷಯಗಳು! ಈ ತಪ್ಪು ಮಾಡ್ಬೇಡಿ -
Best Mutual Funds 2026: ಈ ವರ್ಷ ಉತ್ತಮ ಆದಾಯ ನೀಡುವ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ಗಳಿವು! -
Equity Funds 2025: ಸ್ಪಷ್ಟ ಲಾಭದ ಲಿಡರ್ ಫಂಡ್ಸ್ 2025...ಬ್ಯಾಂಕಿಂಗ್ ಆಟೋ ಹಣಕಾಸು ವಿಭಾಗ ಮುನ್ನಡೆ! -
SBI ಮ್ಯೂಚುವಲ್ ಫಂಡ್ಗಳಿಂದ 5 ಶ್ರೇಷ್ಠ ಹೂಡಿಕೆ ಆಯ್ಕೆಗಳು...ಕಡಿಮೆ ವೆಚ್ಚ, ಹೆಚ್ಚಿನ ಲಾಭ, ದೀರ್ಘಾವಧಿ ಸಂಪತ್ತು!
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+